Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

被引:722
作者
Yan, YK [1 ]
Melchart, M [1 ]
Habtemariam, A [1 ]
Sadler, PJ [1 ]
机构
[1] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
基金
英国惠康基金;
关键词
D O I
10.1039/b508531b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Our work has shown that certain ruthenium(II) arene complexes exhibit promising anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their frameworks provide considerable scope for optimising the design, both in terms of their biological activity and for minimising side-effects by variations in the arene and the other coordinated ligands. Initial studies on amino acids and nucleotides suggest that kinetic and thermodynamic control over a wide spectrum of reactions of Ru(II) arene complexes with biomolecules can be achieved. These Ru( II) arene complexes appear to have an altered profile of biological activity in comparison with metal-based anticancer complexes currently in clinical use or on clinical trial.
引用
收藏
页码:4764 / 4776
页数:13
相关论文
共 98 条
[51]   Ligand exchange reactions of [Re2(μ-OR)3(CO)6]- (R = H, Me) with sulfur, selenium, phosphorus and nitrogen donor ligands, investigated by electrospray mass spectrometry [J].
Jiang, CH ;
Hor, TSA ;
Yan, YK ;
Henderson, W ;
McCaffrey, LJ .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 2000, (18) :3204-3211
[52]   Metal carbonyls: A new class of pharmaceuticals [J].
Johnson, TR ;
Mann, BE ;
Clark, JE ;
Foresti, R ;
Green, CJ ;
Motterlini, R .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (32) :3722-3729
[53]  
Kopf-Maier P, 1994, METAL COMPOUNDS CANC, P109, DOI DOI 10.1007/978-94-011-1252-9_6
[54]  
Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7
[55]  
KROGE RN, 2000, ONKOLOGIE, V23, P60
[56]  
Le Bideau F, 2001, CHEM-EUR J, V7, P2289, DOI 10.1002/1521-3765(20010601)7:11<2289::AID-CHEM22890>3.0.CO
[57]  
2-R
[58]   Acetyl-coenzyme A synthase:: the case for a Nip0-based mechanism of catalysis [J].
Lindahl, PA .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2004, 9 (05) :516-524
[59]  
Lippert B., 1999, CISPLATIN CHEM BIOCH, P183
[60]   Bioorganometallic chemistry.: 13.: Regioselective reduction of NAD+ models, 1-benzylnicotinamde triflate and β-nicotinamide ribose-5′-methyl phosphate, with in situ generated [CP*Rh(Bpy)H]+:: Structure-activity relationships, kinetics, and mechanistic aspects in the formation of the 1,4-NADH derivatives [J].
Lo, HC ;
Leiva, C ;
Buriez, O ;
Kerr, JB ;
Olmstead, MM ;
Fish, RH .
INORGANIC CHEMISTRY, 2001, 40 (26) :6705-6716